KORU Medical Systems Announces Phase III Clinical Trial Collaboration for a New Drug Indication in Nephrology
MAHWAH, N.J.--(BUSINESS WIRE)--KORU Medical Systems (NASDAQ: KRMD) (“KORU Medical” or the “Company”), a leading medical technology company focused on the...